EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Employment, work ability and sick leave in melanoma patients within the first year of diagnosis

Susanne Dugas-Breit iD, Martin Dugas, Hans-Joachim Schulze

JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2025

DOI: 10.1111/ddg.15560 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2025. Verfasst von Susanne Dugas-Breit und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Heidelberg University Hospital, Heidelberg, Germany. Hauptthemen laut MEDLINE: Melanoma, Sick Leave, Employment, Skin Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Rentenversicherung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives Malignant melanoma affects younger working individuals. This study investigated work ability and sick leave within one year after diagnosis, as well as the impact of rehabilitation and psycho‐oncological measures on employment outcomes. Patients and methods In this monocentric, prospective, observational cohort study, 221 patients (62.4% females), aged 19–65, participated. 78.5% had tumor stage IB or lower at baseline. Routine clinical documentation, occupational history, work ability, subjective prognosis of employment, need for and satisfaction with rehabilitation measures were repeatedly assessed.

Results

181 patients (82%) were employed at first visit, 172 (78%) at last visit. Approximately 75% of patients initially rated work ability as “moderate”, with up to 9 sick leave days. In the following year, sick days increased significantly in patients with stage IB and IIA (p = 0.044) and highly significantly in patients with stage II B and above (p < 0.001). Psycho‐oncologic consultation (24%) and rehabilitation (18%) did not change the significantly worse self‐rated work ability of these patients.

Conclusions

Melanoma affects work ability, even in tumor stages without lymph node involvement or distant metastasis. Controlled clinical trials would be useful to evaluate the success of rehabilitation and psycho‐oncological interventions for patients with melanoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSick LeaveEmploymentSkin NeoplasmsWork Capacity EvaluationHumansFemaleMaleMiddle AgedAdultAgedProspective StudiesYoung AdultGermany

Stichwörter der Autor:innen

Cohort studiesemploymentmelanomarehabilitationsick leavework ability

Autor:innen und Institutionen

  • Department of Dermatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Institute of Medical Informatics, Heidelberg University Hospital, Heidelberg, Germany.
  • Department of Dermatology, Fachklinik Hornheide, Münster, Germany.

ORCID-Profile: Susanne Dugas-Breit

Förderung

  • Deutsche Rentenversicherung

Zitieren

APA

Dugas-Breit, S., Dugas, M., & Schulze, H. J. (2025). Employment, work ability and sick leave in melanoma patients within the first year of diagnosis. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15560

Vancouver

Dugas-Breit S, Dugas M, Schulze HJ. Employment, work ability and sick leave in melanoma patients within the first year of diagnosis. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2025. doi:10.1111/ddg.15560

BibTeX
@article{DugasBreit2025,
  author = {Dugas-Breit, Susanne and Dugas, Martin and Schulze, Hans-Joachim},
  title = {Employment, work ability and sick leave in melanoma patients within the first year of diagnosis},
  journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
  year = {2025},
  doi = {10.1111/ddg.15560}
}
Kostenlos starten →